🇺🇸 FDA
Patent

US 12351590

Pyrrolopyrimidine compound and use thereof

granted A61PA61P19/02A61P29/00

Quick answer

US patent 12351590 (Pyrrolopyrimidine compound and use thereof) held by Medshine Discovery Inc. expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Medshine Discovery Inc.
Grant date
Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P19/02, A61P29/00